Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

KULeuven Intensive Insulin Study in Pediatric Intensive Care Patients

NCT00214916 is registered in ClinicalTrials.gov with Greet Van den Berghe as lead sponsor.

NCT NCT00214916
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00214916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
KULeuven Intensive Insulin Study in Pediatric Intensive Care Patients
Lead sponsor
Greet Van den Berghe
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2004
Completion date
June 30, 2023
Enrollment
700 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

critical illness